Arginine Deprivation | List of Frontiers open access articles

Mini Review

Published on 15 Jul 2022

Argininosuccinate synthase 1, arginine deprivation therapy and cancer management

in Pharmacology of Anti-Cancer Drugs

Naihui Sun
Xing Zhao

Frontiers in Pharmacology

doi 10.3389/fphar.2022.935553

11,926 views
33 citations

Review

Published on 22 Aug 2024

Therapeutic potential of arginine deprivation therapy for gliomas: a systematic review of the existing literature

in Experimental Pharmacology and Drug Discovery

Chen Yuxiao
Wang Jiachen
Lan Yanjie
Li Shenglan
Wang Yuji
Li Wenbin

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1446725

6,332 views
7 citations

Original Research

Published on 08 Sep 2022

Preclinical evidence of a direct pro-survival role of arginine deprivation in multiple myeloma

in Cancer Metabolism

Matteo Trudu
Laura Oliva
Ugo Orfanelli
Alessandra Romano
Francesco Di Raimondo
Francesca Sanvito
Maurilio Ponzoni
Simone Cenci

Frontiers in Oncology

doi 10.3389/fonc.2022.968208

6,149 views
6 citations

Review

Published on 11 Feb 2026

Molecular mechanisms and therapies for tumor inhibition through the arginine metabolism pathway

in Molecular and Cellular Oncology

Yuhang Xu
Mingxin Yu
Yi Zhang
Yiqing Jiang
Haiyan Zhu
Shujuan He
Guohua Yu
Niannian Li
Shuzhen Liu
Bin Liu

Frontiers in Oncology

doi 10.3389/fonc.2026.1774392

565 views

Review

Published on 10 Oct 2024

Tumor-associated macrophages and CD8+ T cells: dual players in the pathogenesis of HBV-related HCC

in Cancer Immunity and Immunotherapy

Muhammad Naveed Khan
Binli Mao
Juan Hu
Mengjia Shi
Shunyao Wang
Adeel Ur Rehman
Xiaosong Li

Frontiers in Immunology

doi 10.3389/fimmu.2024.1472430

10,577 views
28 citations

Review

Published on 11 Jul 2022

Targeted Arginine Metabolism Therapy: A Dilemma in Glioma Treatment

in Cancer Metabolism

Xiaoshuang Hou
Sui Chen
Po Zhang
Dongsheng Guo
Baofeng Wang

Frontiers in Oncology

doi 10.3389/fonc.2022.938847

9,258 views
31 citations

Case Report

Published on 06 Mar 2018

Use of Eflornithine (DFMO) in the Treatment of Early Alzheimer's Disease: A Compassionate Use, Single-Case Study

in Alzheimer's Disease and Related Dementias

Jessica Alber
Kelly McGarry
Richard B. Noto
Peter J. Snyder

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2018.00060

5,736 views
19 citations

Articles

Argininosuccinate synthase 1, arginine deprivation therapy and cancer management

Therapeutic potential of arginine deprivation therapy for gliomas: a systematic review of the existing literature

Preclinical evidence of a direct pro-survival role of arginine deprivation in multiple myeloma

Molecular mechanisms and therapies for tumor inhibition through the arginine metabolism pathway

Tumor-associated macrophages and CD8+ T cells: dual players in the pathogenesis of HBV-related HCC

Targeted Arginine Metabolism Therapy: A Dilemma in Glioma Treatment

Use of Eflornithine (DFMO) in the Treatment of Early Alzheimer's Disease: A Compassionate Use, Single-Case Study